NCT04973826View on ClinicalTrials.gov

Study to Assess the Pharmacokinetics, Safety and Tolerability of Aztreonam-Avibactam in Healthy Chinese Participants.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 20, 2021

Primary Completion Date

September 27, 2021

Study Completion Date

September 27, 2021

Conditions

Healthy

Interventions

DRUG

Aztreonam-Avibactam

500/167 mg ATM/AVI loading infusion, followed by 1500/500 mg ATM/AVI extended loading infusion, then 1500/500 mg ATM/AVI maintenance dose infusion every 6 hours

Trial Locations (1)

201107

Huashan Hospital Fudan University, Shanghai